Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record

Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.

Investors Business Daily

AMGN Earnings Spotlight: Analyzing Potential Gains

Drug manufacturer Amgen Inc. (AMGN) is actively pursuing strategic collaborations and making noteworthy strides in the realm of obesity treatments. With the company all set to lift the curtains on its fiscal fourth-quarter earnings tomorrow, would it be prudent to take a bullish stance on the stock now? Keep reading…

StockNews.com

Gilead (GILD) Quarterly Earnings: Buy or Sell Signal?

Biotech major Gilead Sciences (GILD) will release its fourth-quarter results on February 6. The company is expected to report growth in earnings over the prior-year quarter, but its revenue is expected to decline. Given the expected decline in its revenue, how should investors play this stock? Read on to learn…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Novo Holdings Acquires Catalent for .5 Billion, Expands Wegovy Capacity

Novo Holdings has announced its acquisition of Catalent for .5 billion, a move aimed at expanding the production capacity of Wegovy, a drug used for obe...

Top News

Secretive US rightwing group Alec designs law to give big business ‘complete immunity for bad acts’

Group wrote model legislation to restrict lawsuits under public nuisance laws used to hold opioid makers and others to account

The Guardian - US

Pharmacies in England and Scotland to offer private Covid jabs – for £45

Pharmadoctor is offering appointments from 1 April for vaccinations and intends to add more pharmacies to its network

The Guardian - UK

Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

StockNews.com

FTC probe drugmakers’ patent thickets

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"

Salon

3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

StockNews.com

Publicis Settles Opioid Case With US States For $350 Mn

Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday.

International Business Times

Medicare makes opening bid to pharma companies in talks to lower drug costs

Biden administration says public health insurance program has made initial offers for 10 of most commonly used medicines

The Guardian - US

Restricting abortion drug access

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

Salon

AbbVie (ABBV) Earnings Preview: Buy or Sell Opportunities

While AbbVie (ABBV) saw a decrease in net revenues and EPS in the last reported quarter, it raised its 2023 adjusted EPS guidance range. With the company gearing up to report fourth-quarter 2023 results tomorrow, is the stock worth buying today? Keep reading.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Smart Pharma Picks Serving Gains

With rising healthcare expenditure, growing need for precision medicine, innovations in biologics and gene editing, and rapid adoption of advanced technologies, the pharma industry is well-poised for significant growth and expansion. Thus, quality pharma stocks Wave Life (WVE), Teva Pharmaceuticals (TEVA), and Collegium (COLL) could be smart buys for substantial…

StockNews.com

Pharma Stock Analysis: Buy, Hold, or Sell These 4?

Amid rising global medical needs, an aging population, and technological advancements, the pharmaceutical industry is expected to witness robust growth over the coming years. Given this positive backdrop, let’s analyze the investment prospects of pharma stocks Madrigal (MDGL), Pfizer (PFE), Astellas (ALPMY), and Novo Nordisk (NVO). Read on.

The Guardian - UK

Britain’s drug shortages are caused by regulator’s failure

Letters: Mark Samuels on why accessing medicines, from routine to life-changing, is getting harder; Philip Clayton wonders why we don’t manufacture our own drugs

International Business Times

Biogen Pulls Controversial Alzheimer's Drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Merck (MRK): Quarterly Earnings - What Investors Should Know

Pharma giant Merck (MRK) has an impressive record of surpassing analysts’ expectations in its top and bottom lines. So, is the company on track to top estimates in the upcoming earnings release? Let’s discuss some of its financials to gauge its prospects.

StockNews.com

Top 3 Pharma Stocks With Bullish Momentum

The pharmaceutical industry’s future appears increasingly optimistic, encouraged by surging healthcare spending due to the rise of chronic and rare disease incidences and an expanding elderly population. The encouraging prognosis of the industry is further bolstered by unwavering ventures into research and development structures and technological advancements. Given this backdrop,…

StockNews.com

Biotech Stock Success: Top 3 Picks for Monthly Gains

Amid the dynamic biotech landscape, the sector is set to witness an upward trajectory fueled by consistent advancements. Therefore, it could be wise to buy fundamentally strong biotech stocks Protalix BioTherapeutics (PLX), Organogenesis Holdings (ORGO), and ANI Pharmaceuticals (ANIP) for monthly gains. Read more.

International Business Times

Weight-loss Drug Maker Novo Nordisk's Profit Surges As Sales Boom

Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.

Top News

GSK surpasses Q4 estimates, projects 2024 growth

GSK's fourth-quarter results exceeded expectations, signaling company growth in 2024. Learn more about the positive financial outlook for GSK.

StockNews.com

Biotech Bulls: 3 Stocks With Buying Potential

The biotech industry's upward trajectory is being fueled by the advancement of orphan medications, innovative biotech equipment, personalized medicine, and robust government support. Thus, biotech stocks ANI Pharmaceuticals (ANIP), Equillium (EQ), and Exelixis (EXEL) might serve as ideal additions to your portfolio. Read more….

StockNews.com

Pharma Buy, Hold, or Sell: 4 Stocks Worth Considering

The pharmaceutical industry is anticipated to thrive as demand grows and technology advances. However, given the macroeconomic uncertainties, let us analyze leading pharma stocks Zoetis (ZTS), Verano Holding (VRNOF), Canopy Growth (CGC) and SNDL (SNDL) to identify whether they are a Buy, Hold, or Sell. Read on.

1 … 17 18 19 20

People

Dipanjan BanchurSince

722 stories

Lawrence Gostin

36 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.